Sales declined slightly in the first quarter for Goleta breast implant maker Sientra, and net loss rose 8 percent to $28.6 million or 57 cents per share. Revenues of $16.9 million missed analyst estimates, sending shares down 5.6 percent to $2.28 in after-hours trading. The impacts of COVID-19 were strongest in the final weeks of…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
